INDIA LIVE DESKNIFTY 50:23,140.50(+0.34%)SENSEX:73,895.74(+0.43%)
RDU Global
๐Ÿ‡ฎ๐Ÿ‡ณ
Home/Topics/Companies & Institutions/CMC
Back to Newsroom
๐ŸขOrganization Dossier

CMC

Curated news coverage, institutional background, regulatory filings, and investigative reporting across RDU Global.

5 Stories Indexed
Last Updated: Just Now
Verified Entity Intelligence
National Governance & Policy Just now (08:01 PM IST)

CMC Marks World Heart Day With Public Health Drive in Ranipet

The CMC organised a series of events to mark World Heart Day, placing prevention, early screening and lifestyle change at the centre of its public health message. Ranipet Collector N. Priya Ravichandran attended as chief guest, underscoring the local administrationโ€™s support for cardiovascular awareness and community outreach.

By RDU Global Wire5 min read
National Governance & Policy03 Oct 2026, 05:23 AM IST

CMC Opens Paediatric Speciality Centre at Ranipet Campus, Expanding Child Health Capacity in Tamil Nadu

Christian Medical College has opened a dedicated Paediatric Speciality Centre at its Ranipet campus, adding a focused facility for child health services in Tamil Nadu. The move strengthens tertiary paediatric care access in the region and reflects the continuing expansion of specialised healthcare infrastructure beyond major urban centres.

5 min readRead โ†’
National Governance & PolicyJust now (01:55 AM IST)

CMC Marks World Heart Day with Public Health Events in Ranipet

The Christian Medical College organised a series of events to mark World Heart Day, placing renewed emphasis on prevention, early screening and community awareness around cardiovascular disease. Ranipet Collector N. Priya Ravichandran attended as chief guest, underscoring the role of local administration in public health outreach.

5 min readRead โ†’
Global Markets & Equities15 Oct 2026, 02:39 PM IST

FDA Moves to Tighten Rare-Disease Drug Reviews as New Leadership Seeks Consistency

The U.S. Food and Drug Administration is advancing a new rare-disease framework that could reshape how experimental treatments are designed, reviewed and approved. The initiative signals a shift toward greater consistency and broader evidentiary standards, a move that may raise the bar for developers while potentially improving regulatory predictability.

6 min readRead โ†’
Global Health & Biotech15 Oct 2026, 08:50 AM IST

FDA Moves to Tighten Rare-Disease Drug Reviews as New Leadership Seeks Consistency

The U.S. Food and Drug Administration is preparing a broad reset of how rare-disease medicines are evaluated, with new leadership signaling a push for a more consistent, fit-for-purpose framework that could reshape development standards across the sector. The initiative is likely to affect trial design, evidence expectations and manufacturing oversight, with implications for biotech valuations and the pace of future approvals.

5 min readRead โ†’

๐Ÿข About this Entity

Corporations, startups, regulatory bodies, central banks, ministries and judicial courts. All news mentioning this entity is automatically verified and aggregated into this live intelligence dossier.